Source: Pharmacy Times articles
The withdrawal comes after clinical trial results failed to demonstrate the safety and efficacy of melphalan flufenamide when combined with dexamethasone.
Read More
by | Feb 26, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The withdrawal comes after clinical trial results failed to demonstrate the safety and efficacy of melphalan flufenamide when combined with dexamethasone.
Read More